Rocaltrol and Halcion drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rocaltrol (calcitriol) and Halcion (triazolam). Common drug interactions include injection site bruising among females and vomiting among males.
The phase IV clinical study analyzes what interactions people have when they take Rocaltrol and Halcion. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.
What is Rocaltrol?
Rocaltrol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 7,562 Rocaltrol users. Check the latest studies of Rocaltrol.
What is Halcion?
Halcion has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 8,268 Halcion users. Check the latest studies of Halcion.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
45 people who take Rocaltrol and Halcion together, and have interactions are studied.

What are the common drug interactions of Rocaltrol and Halcion, by gender? *:
female:
- Injection site bruising
- International normalised ratio increased
- Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
- Nausea (feeling of having an urge to vomit)
- Oedema lower limb (fluid collection in tissue of lower leg)
- Pallor
- Pleural effusion (water on the lungs)
- Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles)
- Pseudarthrosis (bones that do not heal after fracture)
- Rash pruritic (redness with itching)
male:
- Vomiting
- Dizziness
- Delirium (wild excitement)
- Gait disturbance
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haemodialysis complication
- Lacunar infarction (a type of stroke)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Pneumonia
What are the common drug interactions of Rocaltrol and Halcion, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
50-59:
- Myoglobin urine present
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Vertigo
- Blood glucose increased
- Intervertebral disc protrusion (spinal disc protrusion)
- Osteoporosis (bones weak and more likely to break)
- Pain
- Dizziness
- Vomiting
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
60+:
- Anaemia (lack of blood)
- Pneumonia
- Altered state of consciousness (altered state of mind)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
- Delirium (wild excitement)
- Gait disturbance
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haemodialysis complication
- Lacunar infarction (a type of stroke)
What are the existing conditions these people have? *
- Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 11 people, 24.44%
- High Blood Pressure: 11 people, 24.44%
- Osteoporosis (bones weak and more likely to break): 6 people, 13.33%
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 5 people, 11.11%
- Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 5 people, 11.11%
- Herpes Zoster: 5 people, 11.11%
- Diabetes: 5 people, 11.11%
- Urinary Tract Infection: 4 people, 8.89%
- Pain: 4 people, 8.89%
- Chronic Renal Failure (kidney failure): 4 people, 8.89%
* Approximation only. Some reports may have incomplete information.
Do you take Rocaltrol and Halcion?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Rocaltrol and Halcion:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rocaltrol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Halcion:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocaltrol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Halcion and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on calcitriol and triazolam (the active ingredients of Rocaltrol and Halcion, respectively), and Rocaltrol and Halcion (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Schizophrenia and Eye Rolling - 3 seconds ago
- Could Rapamune cause Hyperhidrosis? - 16 seconds ago
- Could Tacrolimus cause Hepatitis Cholestatic? - 17 seconds ago
- Retinal Vessel Occlusion and Drug Ineffective - 19 seconds ago
- Could Meropenem cause Haematotoxicity? - 20 seconds ago
- Tysabri and Sciatica for Women aged 40-49 - 21 seconds ago
- Tysabri and Sciatic Nerve Dysfunction for Women aged 40-49 - 22 seconds ago
- Tysabri and Neuropathy - Sciatic Nerve for Women aged 40-49 - 22 seconds ago
- Could Gliclazide cause Eye Inflammation? - 22 seconds ago
- Could Ramipril cause Toxic Optic Neuropathy? - 24 seconds ago